Skip to content

Xerox Corp.

United StatesFDA applicant, unverified

Devices
1

What Xerox Corp. makes

Xerox Corp. manufactures the 413A Neonatal Monitor, a device designed for continuous monitoring of vital signs in newborn infants, including heart rate, respiratory rate, and oxygen saturation.

The 413A Neonatal Monitor is classified as Class II under FDA regulations and is listed via 510(k) clearance. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • 413A Neonatal Monitor Ref K800164

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Xerox Corp. have in the registry?

The registry currently lists 1 device for Xerox Corp.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Xerox Corp.'s devices?

Among its 1 most recently registered device, Xerox Corp. has devices listed in FDA 510(k) (1 device).

What risk classes do Xerox Corp.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Xerox Corp.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Xerox Corp. in the registry?

The most recently registered devices listed for Xerox Corp. include 413A NEONATAL MONITOR.

Generated automatically from registry data and not verified by a human reviewer.